Literature DB >> 11493483

SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.

R Sumazaki1, H Kanegane, M Osaki, T Fukushima, M Tsuchida, H Matsukura, K Shinozaki, H Kimura, A Matsui, T Miyawaki.   

Abstract

X-linked lymphoproliferative disease (XLP), a genetic disorder characterized by immunodeficiency to Epstein-Barr virus (EBV) infection, has been linked to mutations in the SH2D1A gene. To search for the occurrence of SH2D1A mutations in Japan, we performed genetic analysis of the SH2D1A gene in 40 males presenting with severe EBV-associated illnesses, including fulminant infectious mononucleosis, EBV-positive lymphoma, and severe chronic active EBV infection. SH2D1A mutations were detected in 10 of these 40 patients. Five of these 10 cases were sporadic. Patients with SH2D1A mutations displayed severe acute infectious mononucleosis with hyperimmunoglobulin M, hypogammaglobulinemia, and B-cell malignant lymphoma. By contrast, chronic active EBV infection was not associated with SH2D1A mutations. XLP survivors exhibited normal levels of circulating EBV-DNA during convalescence, suggesting that SH2D1A protein is not directly responsible for control of EBV replication. Thus, genetic analysis of the SH2D1A gene is particularly useful in the diagnosis of sporadic cases and carriers of XLP. (Blood. 2001;98:1268-1270)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493483     DOI: 10.1182/blood.v98.4.1268

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

Authors:  Lorraine Tracey; Raquel Villuendas; Pablo Ortiz; Ana Dopazo; Inmaculada Spiteri; Luis Lombardia; Jose L Rodríguez-Peralto; Jesús Fernández-Herrera; Almudena Hernández; Javier Fraga; Orlando Dominguez; Javier Herrero; Miguel A Alonso; Joaquin Dopazo; Miguel A Piris
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Fatal primary Epstein-Barr virus infection due to clonal CD8+ T-lymphocyte proliferation in an immunocompetent adult.

Authors:  Naoko Satoh; Tadashi Koike; Hidekichi Takato; Masahiro Fujiwara; Iwao Emura; Hirokazu Kaneganed
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

3.  A case of adolescent primary adrenal natural killer cell lymphoma.

Authors:  Yoko Mizoguchi; Kazuhiro Nakamura; Shin-Ichiro Miyagawa; Shin-Ichiro Nishimura; Koji Arihiro; Masao Kobayashi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

4.  Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children.

Authors:  Masakatsu Yanagimachi; Hiroaki Goto; Takako Miyamae; Keisuke Kadota; Tomoyuki Imagawa; Masaaki Mori; Hidenori Sato; Ryu Yanagisawa; Tetsuji Kaneko; Satoshi Morita; Eiichi Ishii; Shumpei Yokota
Journal:  J Clin Immunol       Date:  2011-09-04       Impact factor: 8.317

Review 5.  X-linked lymphoproliferative disease: genetic lesions and clinical consequences.

Authors:  Andrew J MacGinnitie; Raif Geha
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

6.  Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.

Authors:  B Tóth; B Soltész; E Gyimesi; G Csorba; Á Veres; Á Lányi; G Kovács; L Maródi; M Erdős
Journal:  J Clin Immunol       Date:  2014-12-10       Impact factor: 8.317

7.  X-linked lymphoproliferative disease in an adult.

Authors:  Takumi Hoshino; Hirokazu Kanegane; Noriko Doki; Hiroyuki Irisawa; Tohru Sakura; Yoshihisa Nojima; Shuichi Miyawaki; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

8.  Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.

Authors:  B Hügle; P Suchowerskyj; H Hellebrand; B Adler; M Borte; U Sack; U Schulte Overberg-Schmidt; N Strnad; J Otto; A Meindl; V Schuster
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

9.  Optimal treatment for chronic active Epstein-Barr virus disease.

Authors:  Jeffrey I Cohen
Journal:  Pediatr Transplant       Date:  2009-06

Review 10.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  Gritta E Janka
Journal:  Eur J Pediatr       Date:  2006-12-07       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.